 
            Elon Musk's Neurotechnology Startup to Initiate Human Trial For Brain Implants
Neuralink's PRIME Study, an FDA-approved brain-computer interface trial, aims to empower paralysis patients by wirelessly connecting their thoughts to devices. A milestone in merging technology and healthcare, it offers hope for enhanced independence.
            
         
             
             
             
             
             
             Industry Inscript is a subsidiary of Valiant and Company Ltd.
        Industry Inscript is a subsidiary of Valiant and Company Ltd.